Page 32 - 74_04
P. 32

I. NIETO-VÁZQUEZ Y COLS.  AN. R. ACAD. NAC. FARM

           activation, and impaired atypical protein kinase C (zeta/lambda) activation in
           myotubes from obese patients with impaired glucose tolerance. Diabetes. 51:
           1052-1059.
    (9) HIROSUMI, J.; TUNCMAN, G.; CHANG, L.; GORGUN, C. Z.; UYSAL, K. T.;
           MAEDA, K.; KARIN, M. AND HOTAMISLIGIL, G. S. (2002) A central role for
           JNK in obesity and insulin resistance. Nature. 420: 333-336.
    (10) BENNETT, B. L.; SATOH, Y. AND LEWIS, A. J. (2003) JNK: A new therapeutic
           target for diabetes. Curr. Opin. Pharmacol. 3: 420-425.
    (11) KOREN, S. AND FANTUS, G. (2007) Inhibition of the protein tyrosine
           phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-
           2 diabetes mellitus. Best. Pract. Res. Clin. Endocrinol. Metab. 8: 621-640.
    (12) ELCHEBLY, M.; PAYETTE, P.; MICHALISZYN, E.; CROMLISH, W.; COLLINS, S.;
           LOY, A. L.; NORMANDIN, D.; CHENG, A.; HIMMS-HAGEN, J.; CHAN, C. C.;
           RAMACHANDRAN, C.; GRESSER, M. J.; TREMBLAY, M. L. AND KENNEDY, B. P.
           (1999) Increased insulin sensitivity and obesity resistance in mice lacking the
           protein tyrosine phosphatase-1B gene. Science. 283: 1544-1548.
    (13) KLAMAN, L.D.; BOSS, O.; PERONI, O. D.; KIM, J. K.; MARTINO, J. L.;
           ZABOLOTNY, J. M.; MOGHAL, N.; LUBKIN, M.; KIM, Y. B.; SHARPE, A. H.;
           STRICKER-KRONGRAD, A.; SHULMAN, G. I.; NEEL, B. G. AND KAHN, B. B.
           (2000) Increased energy expenditure, decreased adiposity, and tissue-specific
           insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol.
           Cell Biol. 20: 5479-5489.
    (14) MUSI, N. AND GOODYEAR, L. J. (2003) AMP-activated protein kinase and
           muscle glucose uptake. Acta Physiol Scand. 178: 337-345.
    (15) MU, J.; BROZINICK, J. T. JR.; VALLADARES, O.; BUCAN, M. AND BIRNBAUM, M.
           J. (2001) A role for AMP-activated protein kinase in contraction- and
           hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell. 7: 1085-
           1094.
    (16) ARNER, P. (2003) The adipocyte in insulin resistance: key molecules and the
           impact of the thiazolidinediones. Trends Endocrinol. Metab. 14: 137-145
    (17) HOLST, D. AND GRIMALDI, P. A. (2002) New factors in the regulation of adipose
           differentiation and metabolism. Curr. Opin. Lipidol. 13: 241-245.
    (18) CHEN, G. AND GOEDDEL, D. V. (2002) TNF-R1 signaling: a beautiful pathway.
           Science. 296: 1634-1635.
    (19) WAJANT, H.; PFIZENMAIER, K. AND SCHEURICH, P. (2003) Tumor necrosis
           factor signaling. Cell Death. Differ. 10: 45-65.
    (20) DEMPSEY, P.W.; DOYLE, S. E.; HE, J. Q. AND CHENG, G. (2003) The signaling
           adaptors and pathways activated by TNF superfamily. Cytokine Growth
           Factor Rev. 14: 193-209.
    (21) RUAN, H.; MILES, P. D.; LADD, C. M.; ROSS, K.; GOLUB, T. R.; OLEFSKY, J. M.
           AND LODISH, H. F. (2002) Profiling gene transcription in vivo reveals adipose
           tissue as an immediate target of tumor necrosis factor-alpha: implications for
           insulin resistance. Diabetes. 51: 3176-3188.

30
   27   28   29   30   31   32   33   34   35   36   37